LRG1 and type 2 diabetes mellitus: Work carried out in db/db mice, which are insulin-resistant and commonly used as a mouse model for T2DM, reveals that Lrg1 expression is downregulated in white adipose tissue following treatment with PPARγ agonists [135], anti-inflammatory drugs known to increase insulin sensitivity [136].